The Reality of Virtual Reality

News

Multimedia

Conferences

Publications

Brand Insights

Resources

Sustainability
DE&I
Pandemic
Finance
Legal
Technology
Regulatory
Global
Pricing
Strategy
R&D/Clinical Trials
Opinion
Executive Roundtable
Sales & Marketing
Executive Profiles
Leadership
Market Access
Patient Engagement
Supply Chain
Industry Trends

The Reality of Virtual Reality

March 1, 2001

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-03-01-2001

Of course, Digital Pharma and the drug Virtua are fantasy. But the digital technologies highlighted in the fictional news story are available today.

Articles in this issue

Clinical Work-Up: Amgen's Trials Move Online

The Reality of Virtual Reality

B2B Hot Wire

Buried Treasure: The Stealth Issue of E-Business Taxation

See No Evil

Language, Layout, & Links: Creating Trustworthy Online Messages

Related Content

FDA Approves AOP Health’s Rapiblyk for Atrial Fibrillation and Atrial Flutter

Don Tracy, Associate Editor

November 27th 2024

Article

Approval was based on the combined results from five studies of adults with supraventricular tachycardia.

Key Findings of the NIAGARA and HIMALAYA Trials

Don Tracy, Associate Editor

November 8th 2024

Podcast

In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.

Biden-Harris Administration Proposes Expansion to Medicare and Medicaid to Include Anti-Obesity Medications

Don Tracy, Associate Editor

November 26th 2024

Article

The proposal aims to reduce out-of-pocket costs for a number of anti-obesity medications by 95%.

Fake Weight Loss Drugs: Growing Threat to Consumer Health

Miranda Schmalfuhs

October 25th 2024

Podcast

In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.